Global Blood Therapeutics...

NASDAQ: GBT · Real-Time Price · USD
68.49
0.01 (0.01%)
At close: Oct 04, 2022, 8:00 PM

Global Blood Therapeutics Revenue

Global Blood Therapeutics reported an annual revenue of $194.75M, reflecting a undefined% growth. For the quarter ending June 30, 2022, Global Blood Therapeutics generated $71.55M in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.